Antibiotic Resistance

In what is considered the most comprehensive global study of bacterial antimicrobial resistance (AMR), the peer-reviewed Lancet Medical Journal found that nearly 5 million deaths in 2019 were associated with antibiotic-resistant bacterial infections. In addition, the study found that drug-resistance bacteria accounted for 1.2 million deaths in 2019 – more than HIV and malaria. COVID-19… Continue reading Antibiotic Resistance

Webinar: SARS-COV-2 Omicron Variant of Concern

Join us on December 14th at 11 am EST/8 am PST for a webinar featuring VIGILINT Emergency Medicine Physicians Drs Ossmann and Cellini as they discuss the newly discovered omicron variant and the potential impact on holiday travel. You have questions, and we want to hear from you! Please submit your questions you’d like addressed… Continue reading Webinar: SARS-COV-2 Omicron Variant of Concern

COVID-19 Vaccine for Children & The Pandemic’s Impact on Working Parents

COVID-19 Vaccine Approved for Children 5-11 Kids 5 and up can now get their age-appropriate dose of the COVID-19 vaccine, which is the most effective way to protect against the virus—hard stop. After a year that saw parents scrambling to find ways to protect their children from illness and keep their kids educated in a… Continue reading COVID-19 Vaccine for Children & The Pandemic’s Impact on Working Parents

COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

This chart shows countries/territories ranked by ability to respond to an epidemic/pandemic in 2019. Source: Statista

On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT looks back at the critical events that… Continue reading COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

COVID-19 Update: Convalescent Plasma

Guillermo Legaria/Getty Images

On Sunday, August 23, the US Federal Food and Drug Administration (FDA) announced an Emergency Use Authorization (EUA) for convalescent plasma as a treatment for hospitalized COVID-19 patients citing “known and potential benefits of the product outweigh the known and potential risks of the product.” The EUA would effectively enable physicians to treat COVID-19 patients… Continue reading COVID-19 Update: Convalescent Plasma

COVID-19 Update: The Race for a Vaccine

Vaccine development for COVID-19 is topic number one, and our collective hope for going back to “normal” dangle on that needle. The global race to market includes pharma’s heavy hitters like Pfizer, Johnson & Johnson, AstraZeneca, and Moderna, a Cambridge, Massachusetts-based company that displayed hopeful results in Phase-1 trials and just this week received another… Continue reading COVID-19 Update: The Race for a Vaccine

COVID-19 Update: The Disparity Between the US and the EU COVID-19 Experience

As the US topped a whopping 2.8 million cases and a death count of 130,000 last week, cities and towns across the nation canceled July 4th firework displays and large public gatherings in an effort to prevent further spread of COVID-19. The fervor for holiday travel was scaled down this past weekend compared to prior… Continue reading COVID-19 Update: The Disparity Between the US and the EU COVID-19 Experience

COVID-19 Update: What is the New Normal for Businesses?

Young people with face masks back at work in office after coronavirus quarantine and lockdown.

Once the epicenter of the virus outbreak, the densely populated city of New York endured months of significantly high rates of confirmed infections and reported deaths. As cases began to steadily decrease in the month of May, Governor Cuomo’s daily televised briefs became cautiously more hopeful. As we march towards the official start of summer… Continue reading COVID-19 Update: What is the New Normal for Businesses?

VIGILINT advises global companies on Covid-19 return to work strategies

May 11, 2020, Morrisville, NC:  VIGILINT, a global telemedicine and medical advisory company headquartered in Morrisville, was featured in The Wall Street Journal discussing risk mitigation strategies for global companies’ return-to-work programs.  VIGILINT’s Chief Medical Officer, Eric Ossmann, MD, discussed the company’s newly implemented Virtual Clinic Solutions for COVID-19, designed to help companies protect their employees through critical… Continue reading VIGILINT advises global companies on Covid-19 return to work strategies